Trajectory of weight change after discontinuation of AOMs Overall Overall, compared with control groups, AOM treatment was significantly associated with greater weight regain which varied according to follow-up time point after treatment discontinuation (Fig
Research peptides exist in regulatory gray area
It will: Validate the efficacy signals at larger scale, and at higher resolution Identify predictive markers of safety and tolerability Assess drug-specific differences in different applications Evaluate discontinuation and rebound risk Enable head-to-head drug comparisons as data matures This moves the program from proof-of-concept to clinically actionable stratification
However, consistent results may take some time to fully manifest
The 1mg dose of semaglutide showed a further benefit compared to 1.2mg and 1.7mg of Saxenda at 0.47% and 0.3%, respectively
600 mg per capsule, of which 240 mg pure glutathione